McKechnie Duncan sold VRTX
March 11, 2026 · Form 4 insider transaction
McKechnie Duncan sold 2,633 shares of Vertex Pharmaceuticals Incorporated at $498.42 per share, a transaction worth $1.31M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,633
Price
$498.42
Total value
$1.31M
InsiderMcKechnie Duncan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 11, 2026
Filing dateMarch 13, 2026
Shares owned after12,489
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.